Vericel
ISIN US92346J1088
|WKN A12FU4
Overview
Description
Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.
Healthcare Healthcare Equipment General Medical Devices United States
Chart
Financials
Key metrics
| Market capitalisation, EUR | 2,619.34 m |
| EPS, EUR | 0.06 |
| P/B ratio | 10.96 |
| P/E ratio | 916.16 |
| Dividend yield | 0.00% |
Income statement (2023)
| Revenue, EUR | 182.70 m |
| Net income, EUR | -2.94 m |
| Profit margin | -1.61% |
What ETF is Vericel in?
There are 23 ETFs which contain Vericel. All of these ETFs are listed in the table below. The ETF with the largest weighting of Vericel is the WisdomTree BioRevolution UCITS ETF USD Acc.
| ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
|---|---|---|---|---|---|---|---|---|
| WisdomTree Megatrends UCITS ETF USD | 0.10% | Equity World Social/Environmental Innovation | 645 | 0.50% | 56 | - | A3EYCN | IE0000902GT6 |
| JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (acc) | 0.04% | Equity United States Small Cap | 1,381 | 0.14% | 47 | +36.86% | A3DQ08 | IE000JNKVS10 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (hedged to EUR) A-acc | 0.01% | Equity United States Multi-Factor Strategy | 1,959 | 0.28% | 8 | +27.24% | A2DWAC | IE00BDGV0746 |
| SPDR MSCI ACWI IMI UCITS ETF USD Unhedged (Acc) | 0.00% | Equity World | 3,553 | 0.17% | 2,082 | +28.13% | A1JJTD | IE00B3YLTY66 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (USD) A-acc | 0.01% | Equity United States Multi-Factor Strategy | 1,959 | 0.25% | 84 | +33.49% | A2JSD1 | IE00BDGV0415 |
| SPDR MSCI World Small Cap UCITS ETF | 0.02% | Equity World Small Cap | 3,564 | 0.45% | 904 | +26.30% | A1W56P | IE00BCBJG560 |
| iShares Ageing Population UCITS ETF | 0.22% | Equity World Health Care Social/Environmental Ageing Population | 343 | 0.40% | 378 | +26.24% | A2ANH1 | IE00BYZK4669 |
| iShares S&P SmallCap 600 UCITS ETF | 0.16% | Equity United States Small Cap | 605 | 0.30% | 2,647 | +30.46% | A0Q1YY | IE00B2QWCY14 |
| L&G Russell 2000 US Small Cap Quality UCITS ETF | 0.13% | Equity United States Small Cap | 1,035 | 0.30% | 188 | +31.53% | A0Q8H2 | IE00B3CNHJ55 |
| WisdomTree BioRevolution UCITS ETF USD Acc | 1.81% | Equity World Health Care Social/Environmental Biotech | 89 | 0.45% | 3 | +1.66% | A3CY21 | IE000O8KMPM1 |
| Xtrackers Russell 2000 UCITS ETF 1C | 0.08% | Equity United States Small Cap | 1,497 | 0.30% | 1,828 | +34.22% | A1XEJT | IE00BJZ2DD79 |
| SPDR MSCI ACWI IMI UCITS ETF USD Unhedged (Dist) | 0.00% | Equity World | 3,553 | 0.17% | 11 | - | A40F93 | IE000DD75KQ5 |
| JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) | 0.04% | Equity United States Small Cap | 1,381 | 0.14% | 149 | +35.54% | A3DQ09 | IE0001O84583 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (USD) A-dis | 0.01% | Equity United States Multi-Factor Strategy | 1,959 | 0.25% | 33 | +32.80% | A2DND0 | IE00BDGV0308 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (hedged to CHF) A-acc | 0.01% | Equity United States Multi-Factor Strategy | 1,959 | 0.28% | 25 | +28.08% | A2DWAB | IE00BDGV0C91 |
| iShares MSCI USA Small Cap ESG Enhanced UCITS ETF (Acc) | 0.01% | Equity United States Small Cap | 1,606 | 0.43% | 2,072 | +32.05% | A0X8SB | IE00B3VWM098 |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.21% | Equity United States Health Care Biotech | 214 | 0.35% | 32 | +19.86% | A2JDYM | IE00BDZVHG35 |
| iShares MSCI World Small Cap UCITS ETF | 0.03% | Equity World Small Cap | 3,336 | 0.35% | 4,310 | +25.17% | A2DWBY | IE00BF4RFH31 |
| iShares Nasdaq US Biotechnology UCITS ETF | 0.21% | Equity United States Health Care Biotech | 214 | 0.35% | 440 | +20.83% | A2DWAW | IE00BYXG2H39 |
| SPDR MSCI USA Small Cap Value Weighted UCITS ETF | 0.00% | Equity United States Small Cap | 1,700 | 0.30% | 531 | +33.60% | A12HU5 | IE00BSPLC413 |
| iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc) | 0.01% | Equity World Small Cap | 2,275 | 0.35% | 70 | +25.19% | A3C14G | IE000T9EOCL3 |
| SPDR Russell 2000 US Small Cap UCITS ETF | 0.08% | Equity United States Small Cap | 1,802 | 0.30% | 4,042 | +34.20% | A1XFN1 | IE00BJ38QD84 |
| Amundi S&P SmallCap 600 ESG UCITS ETF UCITS ETF Dist | 0.26% | Equity United States Small Cap | 370 | 0.35% | 401 | +31.75% | ETF039 | IE000XLJ2JQ9 |
Performance
Returns overview
| YTD | +60.09% |
| 1 month | +41.72% |
| 3 months | +25.24% |
| 6 months | +12.30% |
| 1 year | +54.25% |
| 3 years | +39.54% |
| 5 years | - |
| Since inception (MAX) | +5.21% |
| 2023 | +34.09% |
| 2022 | -30.68% |
| 2021 | - |
| 2020 | - |
Monthly returns in a heat map
Risk
Risk metrics in this section:
- Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
- Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
- Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
Risk overview
| Volatility 1 year | 41.01% |
| Volatility 3 years | 51.12% |
| Volatility 5 years | - |
| Return per risk 1 year | 1.32 |
| Return per risk 3 years | 0.23 |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | -27.88% |
| Maximum drawdown 3 years | -51.33% |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | -68.09% |
Rolling 1 year volatility
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.